This exclusive event for hepatology associates offers a unique networking opportunity to share stories, insights, and build meaningful connections.<br />
<br />
Sponsored by: Mirum Pharmaceuticals<br />
&nbsp;

Join your SIG Meet-Up, where you can connect with professionals who share your research and clinical interests! Enjoy light snacks, fun games, and great conversations in a relaxed, informal setting—perfect for networking and building new connections.
<ul>
<li>MASLD Meet-Up&nbsp;</li>
<li>CALD Meet-Up&nbsp;</li>
<li>Clinical Practice Meet-Up&nbsp;</li>
<li>Public Health Meet-Up&nbsp;</li>
<li>Hepatitis C Meet-Up&nbsp;</li>
</ul>

Join AASLD's Diversity, Equity, and Inclusion Committee for this social networking meet-up at the Park Meet at The Liver Meeting. Meet and engage with other attendees interested in diversity and inclusion issues.

This workshop aims to increase interest in hepatology for early learners and expose them to the different training and career options. Presenters also aim to promote successful career growth for those already engaged in a hepatology career by discussing techniques on how to build successful practice models and leadership skills. Attendees have the opportunity to learn from successful hepatology faculty in a variety of career pathways, initially through presentations, followed by a panel discussion. Time is allocated for individual questions with faculty presenters following the workshop.

Experts present 3 cases involving ethical dilemmas in the transplant setting and review options on how clinicians should proceed. Cases address topics on transplantation, who should be listed for transplant (ie, prior history of drug use or alcohol use disorder), and what to do when a patient goes to another country for transplantation.

Liver transplantation for malignancies&mdash;including metastatic colorectal cancer neuroendocrine tumors&mdash;is an emerging area of interest in oncology and transplant medicine. Speakers delve into the latest advancements, clinical outcomes, and patient selection criteria for this innovative approach. Experts share insights into the current evidence, ongoing clinical trials, and the multidisciplinary strategies needed to optimize patient outcomes. The session also includes an in-depth discussion on the feasibility, ethical considerations, and future directions of transplant oncology.<br />
<br />
&nbsp;

Join the AASLD Inclusion and Diversity Committee in exploring the role of social determinants of health, and cultural and language differences in hepatology and liver transplant care. Presenters provide actionable solutions to address these care complexities to optimize health outcomes in patients with liver disease. Additionally, speakers highlight various ways in which community-based research can be conducted to explore these areas of health care in greater detail.

This program from the Liver Fellows Network highlights dual training opportunities with hepatology. Significant overlap exists between hepatology and other specialties such as hepatology-addiction medicine, hepatology-obesity medicine, hepatology-critical care medicine, hepatology-palliative care medicine, and hepatology-advanced endoscopy. Presenters share their personal experiences with dual training focusing on their training journey, current dual training opportunities in their specialty, and integration of the dual training into clinical practice.

Emerging public health data suggest that our environment—the surroundings or conditions in which we live, work, and play—may have substantial impact on the epidemiology of liver disease and the liver health of our communities. In some cases, research in this field may be conflicting, limited in scope, or difficult to translate into clinical practice leading to substantial uncertainty around patient counseling and messaging, and from patients themselves. Presenters summarize and interpret existing research on environmental exposures and liver disease and liver health, including on the development and progression of malignant (HCC and non-HCC primary liver cancers) and nonmalignant (hepatic steatosis, inflammation, fibrosis, and cirrhosis) liver disease.

The debrief sessions summarize the highest impact papers addressing key topics across the field of hepatology presented during The Liver Meeting. A group of original research reports reflecting major advances in hepatology are succinctly reviewed. Debrief 2 will address basic science research, hepatitis, hepatocellular carcinoma, cholestatic liver disease, alcohol-associated liver disease and MetALD, and metabolic dysfunction-associated liver disease.